Tag: Pharmaceuticals

Advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, according to FDA

Eli Lilly, a pharmaceutical company headquartered in Indianapolis, Indiana, received positive news when a panel of independent advisors to the Food and Drug Administration (FDA) recommended the approval of their experimental Alzheimer’s drug, donanemab. The recommendation paves the way for the treatment to receive full approval in the U.S. later this year, expanding treatment options […]

Long-term trial results show promise for Pfizer’s lung cancer drug

Pfizer has announced promising results from a late-stage trial of its drug Lorbrena for advanced lung cancer. The medicine has shown to help patients live longer without cancer progression for over five years, and also reduces the risk of brain progression. Lorbrena is specifically approved for patients with a mutation in the ALK gene, which […]

FDA greenlights new Moderna vaccine for elderly population against respiratory syncytial virus

The Food and Drug Administration recently approved Moderna’s RSV vaccine for adults aged 60 and above, marking the company’s second product to enter the U.S. market. This approval comes at a crucial time for Moderna as it seeks to diversify its revenue streams amidst declining demand for its Covid jab, its only commercially available product. […]

Eli Lilly makes investment to boost supply of Mounjaro and Zepbound

Eli Lilly, a pharmaceutical giant, is making a massive investment in a manufacturing plant in Lebanon, Indiana, to address the high demand for its weight loss drug Zepbound, diabetes treatment Mounjaro, and other medicines. The company is putting in an additional $5.3 billion, bringing its total investment at the site to $9 billion, marking its […]

Understanding Human Cases and Vaccines

The recent detection of bird flu in dairy cows across nine U.S. states has raised concerns among health officials as they monitor and prepare to combat the virus in humans. Despite the low risk to the general public, the presence of the H5N1 strain in livestock and individuals highlights the need for vigilance and effective […]

A potential $25 billion market opportunity for the emerging cancer treatment

Big pharma is making big investments in the field of targeted radiopharmaceutical therapy, which delivers radiation directly into tumors by attaching radioactive particles to targeting molecules. This emerging class of cancer treatments has caught the attention of Wall Street, with RBC Capital Markets estimating a $25 billion market opportunity. Novartis, a market leader in targeted […]

Pfizer introduces latest cost-saving initiative

Pfizer Launches Multiyear Program to Reduce Costs and Rebound from Covid Business Decline Pfizer, the pharmaceutical giant, announced on Wednesday the launch of a new multiyear program aimed at reducing costs and recovering from the rapid decline of its Covid business. This initiative comes on the heels of a previous $4 billion cost-cutting effort that […]

Walgreens to provide affordable opioid overdose medication

In a move to combat the opioid epidemic, Walgreens announced on Wednesday that it will be offering a cheaper version of the over-the-counter opioid overdose reversal spray naloxone. The drug will be available online and in all stores by the end of the month, with the aim of increasing access to this life-saving medication. The […]

Early trial results show promising outcomes for Roche’s new weight loss drug

Roche’s Promising Weight Loss Drug Shows Positive Results in Early-Stage Trial Roche, a multinational healthcare company, has recently announced promising results from an early-stage trial of its experimental weight loss drug, CT-388. The drug, which is still in development, has shown significant potential in helping patients with obesity achieve substantial weight loss. The Swiss company’s […]

Amgen’s small cell lung cancer treatment receives FDA approval

The Food and Drug Administration recently approved Amgen’s therapy for patients with the most deadly form of lung cancer. The drug, to be marketed as Imdelltra, is intended for use as a second or later line of treatment for individuals with advanced small-cell lung cancer. Clinical trials have shown that the drug can reduce tumor […]

Back To Top